MedPath

Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

Phase 4
Completed
Conditions
Coronary Artery Disease
Interventions
Registration Number
NCT01325935
Lead Sponsor
Associations for Establishment of Evidence in Interventions
Brief Summary

A prospective multicenter registry in real-world Japanese patients undergoing DAPT for three months after stenting. To assess the long-term safety of Endeavor Zotarolimus-eluting stent through noninferiority in the primary endpoint between two different continuous regimen (three and twelve months) groups of DAPT after stenting with Endeavor Zotarolimus-eluting stent in real-world Japanese patients and to examine the optimal duration of DAPT after stenting with Endeavor Zotarolimus-eluting stent. The long-term DAPT group in the present clinical study (to be appropriated from the post-marketing surveillance of Endeavor) should consist of consecutive patients undergoing DAPT for twelve months after stenting, while the short-term DAPT group (to be newly registered in the present clinical study) should consist of patients who are instructed to undergo DAPT for three months after stenting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1187
Inclusion Criteria
  1. Clinical inclusion criteria

    • Patient over age 20 years.
    • Patient who is clinically indicated for PCI by stenting at least in one coronary lesion that is visually confirmed by coronary angiography.
    • Patient who has agreed to conditions after receiving an explanation about the contents of the present clinical study and who has signed the consent form approved by the ethical review board at each study site.
    • Patient who has agreed to undergo all clinical FUs listed in the present protocol.
  2. Coronary angiographic inclusion criteria:

    • Patient who has a > 50% occlusion or stenosis that is visually confirmed by coronary angiography in a native coronary artery > 2.5 mm in diameter and in whom the relevant coronary artery has an anatomical structure that is eligible for PCI with Endeavor Zotarolimus-eluting stent.
Exclusion Criteria
  1. Clinical exclusion criteria

    • Patient over age 85 years.
    • Patient with ST elevation MI who requires primary or rescue PCI and whose performance status falls under any of the exclusion criteria.
    • Patient with cardiogenic shock.
    • Patient who underwent stent treatment with BMS in other lesions within 6 months prior to the conduct of index PCI of the target vessel.
    • Patient who has undergone some treatment with DES for coronary lesions.
    • Patient who is scheduled to undergo elective surgery within 12 months after index PCI.
    • Patient whose left ventricular ejection fraction (LVEF) is < 40%.
    • Patient with a hemorrhagic predisposition or a history of coagulation abnormality
    • Patient in whom the total number of deployed stents exceeds 4,regardless of the number of lesions and the number of affected branches.
    • Patient with a verified history of CVA before stenting.
    • Patient with a verified history of active peptic ulcer or upper gastrointestinal tract bleeding before Stenting.
    • Patient showing impaired renal function. (serum creatinine concentration: > 1.8 mg/dL)
    • Patient with known contraindications for aspirin or clopidogrel. (the physician should assess tolerability within the range of routine medical care)
    • Patient with a known disorder who has a life expectancy of less than 12 months.
    • Patient who is incompetent to adhere to all clinical FUs listed in the present protocol.
  2. Angiographic exclusion criteria:

    • Lesions located within the saphenous venin graft (SVG).
    • Unprotected lesions in the left coronary trunk.
    • Lesions of in-stent restenosis in previously deployed DES or BMS.
    • Lesions with an anatomical structure of the coronary artery that is not eligible for treatment by the deployment of Endeavor ZES.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Short-term DAPT groupClopidogrel1,200 patients to be newly registered: Undergo 3-month (+ 30 days) DAPT (aspirin and clopidogrel)
Primary Outcome Measures
NameTimeMethod
NACCE (Net adverse clinical and cerebral event)12 months

NACCE is defined as a composite endpoint consisting of death from some causes (including cardiac death and noncardiac death), myocardial infarction (Q-wave MI and non-Q wave MI), cerebral vascular accident, and major bleeding (as per the modified version of REPLACE-2 criteria for bleeding and as per GUSTO criteria for bleeding).

Secondary Outcome Measures
NameTimeMethod
Stent thrombosis12 months

Incidence of stent thrombosis as per the definition by academic research council

MACE (major adverse cardiac events)1, 3, 6, 9 and 12 months

Incidence of MACE at months 1, 3, 6, 9, and 12 after stenting. MACE is defined as a composite endpoint consisting of cardiac death from some causes (including cardiac and noncardiac death), MI (Q-wave MI and non-Q wave MI), TLR, and coronary artery bypass graft (CABG).

TVR (target vessel revascularization)9 and 12 months

Incidence of target vessel revascularization at months 9 and 12 after stenting.

DAPT compliance12 months

Duration of DAPT and patient compliance.

TLR (target lesion revascularization)9 and 12 months

Incidence of target lesion revascularization at months 9 and 12 after stenting.

Hemorrhagic complications12 months

Incidence of hemorrhagic complications. (as per the modified version of REPLACE-2 criteria for bleeding and as per GUSTO criteria for bleeding)

Trial Locations

Locations (112)

Kimitsu Chuo Hospital

🇯🇵

Kisarazu City, Chiba, Japan

Fukui Cardiovascular Center

🇯🇵

Fukui City, Fukui, Japan

Fukuoka City Medical Association Hospital

🇯🇵

Fukuoka City, Fukuoka, Japan

Fukuoka Red Cross Hospital

🇯🇵

Fukuoka City, Fukuoka, Japan

University of Occupational and Environmental Health

🇯🇵

Kita-Kyushu City, Fukuoka, Japan

National Hospital Organization Fukuoka-Higashi Medical Center

🇯🇵

Koga City, Fukuoka, Japan

Tsuchiya General Hospital

🇯🇵

Hiroshima City, Hiroshima, Japan

Fukuyama City Hospital

🇯🇵

Fukuyama City, Hiroshima, Japan

Gifu Heart Center

🇯🇵

Gifu City, Gifu, Japan

Hyogo Prefectural Amagasaki Hospital

🇯🇵

Amagasaki City, Hyogo, Japan

Miki City Hospital

🇯🇵

Miki City, Hyogo, Japan

Kobe City Medical Center General Hospital

🇯🇵

Kobe City, Hyogo, Japan

Meiwa General Hospital

🇯🇵

Nishinomiya City, Hyogo, Japan

Shakaihoken Kobe Central Hospital

🇯🇵

Kobe City, Hyogo, Japan

Hyogo College of Medicine

🇯🇵

Nishinomiya City, Hyogo, Japan

Tenyoukai Central Hospital

🇯🇵

Kagoshima City, Kagoshima, Japan

Hyogo Prefectural Awaji Hospital

🇯🇵

Sumoto City, Hyogo, Japan

Kanazawa University Hospital

🇯🇵

Kanazawa City, Ishikawa, Japan

Kaisei General Hospital

🇯🇵

Sakaide City, Kagawa, Japan

Kagoshima University Hospital

🇯🇵

Kagoshima City, Kagoshima, Japan

Fujisawa City Hospital

🇯🇵

Fujisawa City, Kanagawa, Japan

Ebina General Hospital

🇯🇵

Ebina City, Kanagawa, Japan

Kawasaki Municipal Tama Hospital

🇯🇵

Kawasaki City, Kanagawa, Japan

St. Marianna University of Medicine, Toyoko Hospital

🇯🇵

Kawasaki City, Kanagawa, Japan

St. Marianna University School of Medicine

🇯🇵

Kawasaki City, Kanagawa, Japan

Odawara Cardiovascular Hospital

🇯🇵

Odawara City, Kanagawa, Japan

Synthesis Shinkawahashi Hospital

🇯🇵

Kawasaki City, Kanagawa, Japan

Kitazato University School of Medicine

🇯🇵

Sagamihara City, Kanagawa, Japan

Saiseikai Yokohama Tobu Hospital

🇯🇵

Yokohama City, Kanagawa, Japan

Showa University Fujigaoka Hospital

🇯🇵

Yokohama City, Kanagawa, Japan

St. Marianna University of Medicine, Yokohama City West Hospital

🇯🇵

Yokohama City, Kanagawa, Japan

Kumamoto Red Cross Hospital

🇯🇵

Kumamoto City, Kumamoto, Japan

National Hospital Organization Kumamoto Medical Center

🇯🇵

Kumamoto City, Kumamoto, Japan

Saiseikai Kumamoto Hospital

🇯🇵

Kumamoto City, Kumamoto, Japan

Ijinkai Takeda General Hospital

🇯🇵

Kyoto City, Kyoto, Japan

Koseikai Takeda Hospital

🇯🇵

Kyoto City, Kyoto, Japan

Kyoto Second Red Cross Hospital

🇯🇵

Kyoto City, Kyoto, Japan

Gakken The Holy City Medical Association Hospital

🇯🇵

Sagara-gun, Kyoto, Japan

Suzuka Central General Hospital

🇯🇵

Suzuka City, Mie, Japan

Uji Tokushukai Hospital

🇯🇵

Uji City, Kyoto, Japan

Mie Heart Center

🇯🇵

Taki-gun, Mie, Japan

Mie University Hospital

🇯🇵

Tsu City, Mie, Japan

Nagasaki University Graduate School of Biomedical Science

🇯🇵

Nagasaki City, Nagasaki, Japan

Kawasaki Medical School

🇯🇵

Kurashiki City, Okayama, Japan

The Sakakibara Heart Institute of Okayama

🇯🇵

Okayama City, Okayama, Japan

Nakagami Hospital

🇯🇵

Okinawa City, Okinawa, Japan

Ohama Daiichi Hospital

🇯🇵

Naha City, Okinawa, Japan

Urasoe General Hospital

🇯🇵

Urasoe City, Okinawa, Japan

Kawachi General Hospital

🇯🇵

Higashi Osaka City, Osaka, Japan

Okinawa Nanbu Tokushukai Hospital

🇯🇵

Shimajiri-gun, Okinawa, Japan

Kansai Medical University Hirakata Hospital

🇯🇵

Hirakata City, Osaka, Japan

Kansai Medical University Takii Hospital

🇯🇵

Moriguchi City, Osaka, Japan

Komatsu General Hospital

🇯🇵

Neyagawa City, Osaka, Japan

Nissay Hospital

🇯🇵

Osaka City, Osaka, Japan

Higashi-sumiyoshi Morimoto Hospital

🇯🇵

Osaka City, Osaka, Japan

Osaka City University, Graduate School of Medicine

🇯🇵

Osaka City, Osaka, Japan

Osaka Ekisaikai Hospital

🇯🇵

Osaka City, Osaka, Japan

Osaka General Medical Center

🇯🇵

Osaka City, Osaka, Japan

Osaka General Hospital of West Japan Railway Campany

🇯🇵

Osaka City, Osaka, Japan

Osaka Gyoumeikan Hospital

🇯🇵

Osaka City, Osaka, Japan

Sakurabashi Watanabe Hospital

🇯🇵

Osaka City, Osaka, Japan

Mimihara General Hospital

🇯🇵

Sakai City, Osaka, Japan

Osaka Police Hospital

🇯🇵

Osaka City, Osaka, Japan

Bell Land General Hospital

🇯🇵

Sakai City, Osaka, Japan

Osaka University Graduate School of Medicine

🇯🇵

Suita City, Osaka, Japan

Hokusetsu General Hospital

🇯🇵

Takatsuki City, Osaka, Japan

Department of Cardiovascular Medicine, Saga University

🇯🇵

Saga City, Saga, Japan

Mashiko Hospital

🇯🇵

Kawaguchi City, Saitama, Japan

Saitama Medical Center, Jichi Medical University

🇯🇵

Saitama City, Saitama, Japan

Kusatsu Heart Center

🇯🇵

Kusatsu City, Shiga, Japan

Omihachiman Community Medical Center

🇯🇵

Omihachiman City, Shiga, Japan

Shiga Medical Center for Adults

🇯🇵

Moriyama City, Shiga, Japan

Biwako Ohashi Hospital

🇯🇵

Otsu City, Shiga, Japan

The University of Tokyo Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

Ayase Heart Hospital

🇯🇵

Adachi-ku, Tokyo, Japan

Tokushima Red Cross Hospital

🇯🇵

Komatsujima City, Tokushima, Japan

Sakakibara Heart Institute

🇯🇵

Fuchu City, Tokyo, Japan

Tokyo Metroporitan Tama Medical Center

🇯🇵

Fuchu City, Tokyo, Japan

Itabashi Chuo Medical Center

🇯🇵

Itabashi-ku, Tokyo, Japan

Tokyo Metroporitan Geriatric Hospital and Institute of Gerontology

🇯🇵

Itabashi-ku, Tokyo, Japan

Toho University Medical Center Ohashi Hospital

🇯🇵

Meguro-ku, Tokyo, Japan

The Cardiovascular Institute

🇯🇵

Minato-ku, Tokyo, Japan

NTT Medical Center Tokyo

🇯🇵

Shinagawa-ku, Tokyo, Japan

Tottri University

🇯🇵

Yonago City, Tottri, Japan

Non-profit organization Associations for Establishiment of Evidence in Interventions

🇯🇵

Minato-ku, Tokyo, Japan

Hiroshima Railway Hospital

🇯🇵

Hiroshima City, Hiroshima, Japan

Sugimura Hospital

🇯🇵

Kumamoto City, Kumamoto, Japan

National Hospital Organization Okayama Medical Center

🇯🇵

Okayama City, Okayama, Japan

St. Luke's International Hospital

🇯🇵

Chuo-ku, Tokyo, Japan

Nihon University School of Medicine

🇯🇵

Itabashi-ku, Tokyo, Japan

Asahi General Hospital

🇯🇵

Asahi City, Chiba, Japan

Fukuoka City Hospital

🇯🇵

Fukuoka City, Fukuoka, Japan

Yokohama City UNiversity Medical Center

🇯🇵

Yokohama City, Kanagawa, Japan

Kumamoto Chuo Hospital

🇯🇵

Kumamoto City, Kumamoto, Japan

Saiseikai Senri Hospital

🇯🇵

Suita City, Osaka, Japan

JR Tokyo General Hospital

🇯🇵

Shibuya-ku, Tokyo, Japan

Matsuzaka Central General Hospital

🇯🇵

Matsuzaka City, Mie, Japan

National Cerebral and Cardiovascular Center

🇯🇵

Suita City, Osaka, Japan

Midorigaoka Hospital

🇯🇵

Takatsuki City, Osaka, Japan

Hamamatsu Medical Center

🇯🇵

Hamamatsu City, Shizuoka, Japan

Juntendo University Shizuoka Hospital

🇯🇵

Izunokuni City, Shizuoka, Japan

Engaru-Kosei General Hospital

🇯🇵

Monbetsu-gun, Hokkaido, Japan

Kanagawa Cardiovascular and Reppiratory Center

🇯🇵

Yokohama City, Kanagawa, Japan

Osaka City General Hospital

🇯🇵

Osaka City, Osaka, Japan

Kansai Rosai Hospital, Cardiovascular Center

🇯🇵

Amagasaki City, Hyogo, Japan

Sagamihara Kyodo Hospital

🇯🇵

Sagamihara City, Kanagawa, Japan

Yokohama City University Hospital

🇯🇵

Yokohama City, Kanagawa, Japan

Seirei Hamamatsu General Hospital

🇯🇵

Hamamatsu City, Shizuoka, Japan

Juntendo University Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

Shuto General Hospital

🇯🇵

Yanai City, Yamaguchi, Japan

The Jikei University Hospital

🇯🇵

Minato-ku, Tokyo, Japan

Teikyo University Hospital

🇯🇵

Itabashi-ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath